Eradication of Small Intestinal Bacterial Overgrowth in Systemic Sclerosis: Current Treatment and Perspectives—A Narrative Review

Small intestinal bacterial overgrowth (SIBO) is a major yet underrecognized driver of gastrointestinal morbidity in systemic sclerosis (SSc). Disordered motility, fibrosis, and dysbiosis promote microbial stasis, malabsorption, and malnutrition, contributing substantially to impaired quality of life...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Mislav Radić, Andrej Belančić, Marijana Vučković, Almir Fajkić, Marija Rogoznica Pavlović, Josipa Radić
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2025-11-01
Serija:	Biomedicines
Teme:	systemic sclerosis small intestinal bacterial overgrowth SIBO gut microbiota gastrointestinal dysmotility antibiotic therapy
Online dostop:	https://www.mdpi.com/2227-9059/13/12/2932
Oznake:	Označite Brez oznak, prvi označite!